Organox Metra®获得FDA批准可在空中运输期间运行，扩大救命肝脏灌注技术的使用范围。
这一重要批准标志着肝脏灌注技术在器官移植领域的重大突破，使得这项救命技术能够在空中运输过程中继续发挥作用，为更多需要肝脏移植的患者带来希望。
FDA的批准意味着Organox Metra®系统现在可以在飞机运输期间保持肝脏的活力和功能，这将显著扩大器官移植的地理范围，让更多偏远地区的患者能够获得合适的肝脏器官。
这项技术的应用将有助于提高器官移植的成功率，同时减少器官在运输过程中的损耗，为急需肝脏移植的患者提供更好的治疗机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.